Skip to main content

Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343)

Publication ,  Journal Article
Serra, V; Eichhorn, PJA; García-García, C; Ibrahim, YH; Prudkin, L; Sánchez, G; Rodríguez, O; Antón, P; Parra, JL; Marlow, S; Scaltriti, M ...
Published in: Journal of Clinical Investigation
March 3, 2014

Duke Scholars

Published In

Journal of Clinical Investigation

DOI

EISSN

1558-8238

ISSN

0021-9738

Publication Date

March 3, 2014

Volume

124

Issue

3

Start / End Page

1418

Related Subject Headings

  • Immunology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Serra, V., Eichhorn, P. J. A., García-García, C., Ibrahim, Y. H., Prudkin, L., Sánchez, G., … Baselga, J. (2014). Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343). Journal of Clinical Investigation, 124(3), 1418. https://doi.org/10.1172/JCI75534
Serra, V., P. J. A. Eichhorn, C. García-García, Y. H. Ibrahim, L. Prudkin, G. Sánchez, O. Rodríguez, et al. “Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343).” Journal of Clinical Investigation 124, no. 3 (March 3, 2014): 1418. https://doi.org/10.1172/JCI75534.
Serra V, Eichhorn PJA, García-García C, Ibrahim YH, Prudkin L, Sánchez G, et al. Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343). Journal of Clinical Investigation. 2014 Mar 3;124(3):1418.
Serra, V., et al. “Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343).” Journal of Clinical Investigation, vol. 124, no. 3, Mar. 2014, p. 1418. Scopus, doi:10.1172/JCI75534.
Serra V, Eichhorn PJA, García-García C, Ibrahim YH, Prudkin L, Sánchez G, Rodríguez O, Antón P, Parra JL, Marlow S, Scaltriti M, Pérez-Garcia J, Prat A, Arribas J, Hahn WC, Kim SY, Baselga J. Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343). Journal of Clinical Investigation. 2014 Mar 3;124(3):1418.

Published In

Journal of Clinical Investigation

DOI

EISSN

1558-8238

ISSN

0021-9738

Publication Date

March 3, 2014

Volume

124

Issue

3

Start / End Page

1418

Related Subject Headings

  • Immunology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 11 Medical and Health Sciences